Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) EPS (Basic): 2020-2025

Historic EPS (Basic) for IDEAYA Biosciences (IDYA) over the last 4 years, with Sep 2025 value amounting to $1.35.

  • IDEAYA Biosciences' EPS (Basic) rose 325.00% to $1.35 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.48, marking a year-over-year increase of 36.48%. This contributed to the annual value of -$3.36 for FY2024, which is 71.43% down from last year.
  • As of Q3 2025, IDEAYA Biosciences' EPS (Basic) stood at $1.35, which was up 187.10% from -$1.55 recorded in Q4 2024.
  • IDEAYA Biosciences' EPS (Basic)'s 5-year high stood at $1.35 during Q3 2025, with a 5-year trough of -$1.55 in Q4 2024.
  • For the 3-year period, IDEAYA Biosciences' EPS (Basic) averaged around -$0.44, with its median value being -$0.52 (2023).
  • In the last 5 years, IDEAYA Biosciences' EPS (Basic) crashed by 1,250.00% in 2023 and then spiked by 325.00% in 2025.
  • Quarterly analysis of 5 years shows IDEAYA Biosciences' EPS (Basic) stood at -$0.49 in 2021, then decreased by 10.20% to -$0.54 in 2022, then climbed by 3.70% to -$0.52 in 2023, then plummeted by 198.08% to -$1.55 in 2024, then skyrocketed by 325.00% to $1.35 in 2025.
  • Its last three reported values are $1.35 in Q3 2025, -$1.55 for Q4 2024, and -$0.60 during Q3 2024.